dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
LEOPARD: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema (clinicaltrials.gov) - Mar 7, 2023 - P2 | N=24 | Not yet recruiting | Sponsor: Quan Dong Nguyen | Initiation date: Dec 2022 ➔ Mar 2023 
Trial initiation date • Macular Edema • Ocular Inflammation • Ophthalmology • Uveitis
http://clinicaltrials.gov/ct2/show/NCT05608837
 
Mar 7, 2023
 
Prev Next